Editors' ChoiceImmunology

Papers of note in Science Translational Medicine 9 (389)

See allHide authors and affiliations

Science Signaling  16 May 2017:
Vol. 10, Issue 479, eaan6297
DOI: 10.1126/scisignal.aan6297

This week’s articles highlight how tumor-associated macrophages limit the efficacy of PD-1–targeted checkpoint therapy and show that an anti-inflammatory drug may be used to treat lymphedema.

View Full Text

Stay Connected to Science Signaling